United Health Products (UEEC) Cash from Financing Activities (2010 - 2026)
United Health Products (UEEC) reported Cash from Financing Activities of $20119.0 for Q1 2026, down 81.71% year-over-year from $110000.0 in Q1 2025, and down 96.65% quarter-over-quarter from $600000.0 in Q4 2025.
United Health Products (UEEC) Cash from Financing Activities (2010 - 2026) Analysis & Trends
United Health Products (UEEC) has 17 years of Cash from Financing Activities data on file, last reported at $20119.0 in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $20119.0, down 81.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $993427.0 (up 0.66% YoY), and the FY2025 annual result was $1.1 million, down 14.58% from the prior year.
- Cash from Financing Activities slipped to $20119.0 in Q1 2026 per UEEC's latest filing, from $600000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $600000.0 in Q4 2025 and troughed at $20119.0 in Q1 2026.
- A 5-year average of $312290.7 and a median of $247372.0 in 2022 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2023 and 2026: Cash from Financing Activities jumped 490.2% in 2023, then plunged 81.71% in 2026.
- A 5-year view of Cash from Financing Activities shows it stood at $135115.0 in 2022, then surged by 342.5% to $597881.0 in 2023, then sank by 48.73% to $306538.0 in 2024, then surged by 95.73% to $600000.0 in 2025, then sank by 96.65% to $20119.0 in 2026.
- Business Quant data shows UEEC's Cash from Financing Activities at $20119.0 in Q1 2026, $600000.0 in Q4 2025, and $193308.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | United Health Products | - | - | - | 20,119.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,119.00 |
| Mar 31, 2026 | 20,119.00 |
| Dec 31, 2025 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 193,308.00 |
| Sep 30, 2025 | 193,308.00 |
| Jun 30, 2025 | 180,000.00 |
| Jun 30, 2025 | 180,000.00 |
| Mar 31, 2025 | 110,000.00 |
| Mar 31, 2025 | 110,000.00 |
| Dec 31, 2024 | 306,538.00 |
| Dec 31, 2024 | 306,538.00 |
| Sep 30, 2024 | 344,826.00 |
| Sep 30, 2024 | 344,826.00 |
| Jun 30, 2024 | 225,590.00 |
| Jun 30, 2024 | 225,590.00 |
| Mar 31, 2024 | 391,225.00 |
| Mar 31, 2024 | 391,225.00 |
| Dec 31, 2023 | 597,881.00 |
| Dec 31, 2023 | 597,881.00 |